Liver problems — XALKORI may cause life-threatening liver injury that may lead to death. Your healthcare provider should do blood tests to check your liver every 2 weeks during the first 2 months of treatment with XALKORI, then once a month. Tell your healthcare provider right away if you get any of the following new or worsening symptoms:

<strong>Personalized Support Resources</strong>

Care Champion support

At Pfizer Oncology Together, our Care Champions, who have social work experience, can provide you resources that may help with some of your day-to-day challenges*:


We can connect you to diagnosis-specific support groups, an independent organization that offers short-term counseling, and a free app, developed by Pfizer Oncology, to help patients connect with loved ones and ask for the support they need.


To help support your overall health and well-being, we’ve created resources about physical and mental health, as well as nutrition tips and healthy recipes developed in partnership with dietitians who specialize in oncology nutrition. We can also provide you with information to help you understand your prescribed XALKORI.


If you need assistance with transportation or lodging for treatment-related appointments, we’ll connect you to independent organizations that offer these services for free to qualifying patients. And if you’re leaving work for a period of time during treatment, or preparing to return to work, we can send you information to help make the transition easier.

Patient CTA Image

*Some services are provided through third-party patient advocacy organizations.


If you’d like more information about XALKORI® (crizotinib), non-small cell lung cancer (NSCLC), biomarker-driven therapy, or the ALK and ROS1 genes, you may want to start with the following downloads and links.

Printable Resources

Download and print these useful documents. They’ll help educate you about NSCLC, ALK and ROS1 testing, as well as XALKORI. They’ll also prepare you for what to expect while taking XALKORI.


This brochure will provide information about XALKORI as a treatment for ALK-positive (ALK+) or ROS1-positve (ROS1+) metastatic NSCLC to help you get the most out of your treatment and understand what to expect.

Discussion Guide

This guide is meant to educate you on the roles and responsibilities of the members of your care team, with an emphasis on how to talk to your doctors, nurses, and loved ones.

Xalkori (crizotinib) Discussion Guide
Biomarker Testing Guide & Glossary

This guide and glossary is meant to educate you about biomarker testing and medical language associated with understanding XALKORI and ALK-positive (ALK+) or ROS1-positive (ROS1+) metastatic NSCLC.

Biomarker Testing Guide and Glossary
Financial Assistance Brochure

This brochure explains how to get XALKORI and details the financial assistance programs from Pfizer that may help you pay for your medicine.

Useful links

Additional education and support for your treatment journey

If you’d like to explore other resources to learn more about cancer care and how it’s changing, consider the following:

It's also a good idea to check with your hospital or cancer care team for information about support groups near you.

Third-party websites being linked to are neither owned or controlled by Pfizer.
Pfizer does not endorse and is not responsible for the content or services of these sites.

XALKORI® (crizotinib) Rx Resources | Safety Info
Learn about personalized patient support & find downloadable resources for XALKORI®, an Rx option for ALK+ or ROS1+ mNSCLC. See risks & benefits.